NO305397B1 - Kinuklidinesterprosess og mellomprodukter ved fremstilling av kinuklidinestere og farmas°ytiske sammensetninger inneholdende dem - Google Patents

Kinuklidinesterprosess og mellomprodukter ved fremstilling av kinuklidinestere og farmas°ytiske sammensetninger inneholdende dem

Info

Publication number
NO305397B1
NO305397B1 NO940905A NO940905A NO305397B1 NO 305397 B1 NO305397 B1 NO 305397B1 NO 940905 A NO940905 A NO 940905A NO 940905 A NO940905 A NO 940905A NO 305397 B1 NO305397 B1 NO 305397B1
Authority
NO
Norway
Prior art keywords
pct
kinuclidine
intermediates
preparation
alkyl
Prior art date
Application number
NO940905A
Other languages
English (en)
Norwegian (no)
Other versions
NO940905L (no
NO940905D0 (no
Inventor
Peter Edward Cross
Alan Stobie
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO940905L publication Critical patent/NO940905L/no
Publication of NO940905D0 publication Critical patent/NO940905D0/no
Publication of NO305397B1 publication Critical patent/NO305397B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO940905A 1991-09-14 1994-03-14 Kinuklidinesterprosess og mellomprodukter ved fremstilling av kinuklidinestere og farmas°ytiske sammensetninger inneholdende dem NO305397B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919119705A GB9119705D0 (en) 1991-09-14 1991-09-14 Therapeutic compounds
PCT/EP1992/002067 WO1993006098A1 (en) 1991-09-14 1992-09-03 Quinuclidine esters process and intermediate for their preparation and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
NO940905L NO940905L (no) 1994-03-14
NO940905D0 NO940905D0 (no) 1994-03-14
NO305397B1 true NO305397B1 (no) 1999-05-25

Family

ID=10701448

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940905A NO305397B1 (no) 1991-09-14 1994-03-14 Kinuklidinesterprosess og mellomprodukter ved fremstilling av kinuklidinestere og farmas°ytiske sammensetninger inneholdende dem

Country Status (31)

Country Link
US (1) US5543419A (es)
EP (1) EP0603229B1 (es)
JP (2) JP2672030B2 (es)
KR (1) KR0135784B1 (es)
CN (1) CN1037269C (es)
AT (1) ATE167187T1 (es)
AU (1) AU659487B2 (es)
BR (1) BR9206499A (es)
CA (1) CA2116356C (es)
CZ (1) CZ281752B6 (es)
DE (1) DE69225897T2 (es)
DK (1) DK0603229T3 (es)
EG (1) EG20072A (es)
ES (1) ES2116343T3 (es)
FI (1) FI114707B (es)
GB (1) GB9119705D0 (es)
GR (1) GR3027667T3 (es)
HU (1) HU220594B1 (es)
IL (1) IL103078A (es)
MX (1) MX9205221A (es)
MY (1) MY108602A (es)
NO (1) NO305397B1 (es)
NZ (1) NZ244324A (es)
PL (1) PL170627B1 (es)
PT (1) PT100863B (es)
RU (1) RU2117669C1 (es)
SG (1) SG50414A1 (es)
TW (1) TW251285B (es)
UA (1) UA42686C2 (es)
WO (1) WO1993006098A1 (es)
ZA (1) ZA926939B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0785198B1 (de) 1996-01-19 2000-07-05 Lonza Ag Verfahren zur Herstellung von optisch aktivem 3-Chinuclidinol
CZ54498A3 (cs) * 1997-03-07 1998-11-11 Lonza Ag Katalyzátorová směs na bázi amorfního částečně dehydratovaného hydroxidu zirkoničitého a způsob její výroby a použití
US6711436B1 (en) 1997-08-08 2004-03-23 Duke University Compositions, apparatus and methods for facilitating surgical procedures
AU758370B2 (en) * 1997-08-08 2003-03-20 Duke University Compositions, apparatus and methods for facilitating surgical procedures
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
JP4445704B2 (ja) 2000-12-22 2010-04-07 アルミラル・ソシエダッド・アノニマ キヌクリジンカルバメート誘導体およびm3アンダゴニストとしてのそれらの使用
IL156558A0 (en) 2000-12-28 2004-01-04 Almirall Prodesfarma Ag Novel quinuclidine derivatives and medicinal compositions containing the same
GB0424284D0 (en) * 2004-11-02 2004-12-01 Novartis Ag Organic compounds
DE102004057995A1 (de) * 2004-12-01 2006-06-08 Wacker Chemie Ag Verfahren zur Herstellung von α,α-Dialkyl-α-Hydroxymethyl-Carbonsäurederivaten
ES2298049B1 (es) * 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
US20100112061A1 (en) * 2006-12-13 2010-05-06 William Baker Monophosphates as Mutual Prodrugs of Muscarinic Receptor Antagonists and Beta-Agonists for the Treatment of COPD And Chronic Bronchitis
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843074A (en) * 1988-05-17 1989-06-27 Marion Laboratories, Inc. 1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts
GB8923590D0 (en) * 1989-10-19 1989-12-06 Pfizer Ltd Antimuscarinic bronchodilators

Also Published As

Publication number Publication date
GB9119705D0 (en) 1991-10-30
EP0603229A1 (en) 1994-06-29
HUT66772A (en) 1994-12-28
PT100863B (pt) 1999-07-30
NZ244324A (en) 1993-12-23
WO1993006098A1 (en) 1993-04-01
JPH09315970A (ja) 1997-12-09
FI941170A0 (fi) 1994-03-11
NO940905L (no) 1994-03-14
US5543419A (en) 1996-08-06
AU659487B2 (en) 1995-05-18
BR9206499A (pt) 1995-11-21
HU220594B1 (hu) 2002-03-28
MX9205221A (es) 1993-03-01
JPH06510991A (ja) 1994-12-08
IL103078A0 (en) 1993-02-21
RU2117669C1 (ru) 1998-08-20
JP2672030B2 (ja) 1997-11-05
PT100863A (pt) 1993-10-29
DK0603229T3 (da) 1998-10-12
PL170627B1 (en) 1997-01-31
GR3027667T3 (en) 1998-11-30
CN1037269C (zh) 1998-02-04
ZA926939B (en) 1994-03-11
EG20072A (en) 1999-06-30
KR0135784B1 (ko) 1998-04-23
CN1070911A (zh) 1993-04-14
IL103078A (en) 1996-07-23
MY108602A (en) 1996-10-31
HU9400729D0 (en) 1994-06-28
ES2116343T3 (es) 1998-07-16
ATE167187T1 (de) 1998-06-15
TW251285B (es) 1995-07-11
DE69225897T2 (de) 1998-10-15
FI114707B (fi) 2004-12-15
FI941170L (fi) 1994-03-11
JP2955533B2 (ja) 1999-10-04
DE69225897D1 (de) 1998-07-16
CA2116356A1 (en) 1993-04-01
AU2482392A (en) 1993-04-27
EP0603229B1 (en) 1998-06-10
CA2116356C (en) 1998-03-31
UA42686C2 (uk) 2001-11-15
NO940905D0 (no) 1994-03-14
CZ281752B6 (cs) 1997-01-15
SG50414A1 (en) 1998-07-20
CZ395392A3 (en) 1994-07-13

Similar Documents

Publication Publication Date Title
NO305397B1 (no) Kinuklidinesterprosess og mellomprodukter ved fremstilling av kinuklidinestere og farmas°ytiske sammensetninger inneholdende dem
HU906495D0 (en) Process for producing compounds and pharmaceutical preparatives of anti-muscarinic effect
NZ335363A (en) Naphthyridine derivatives
AU659279B2 (en) Pyrimidine derivatives
GR3034769T3 (en) Triazole antifungal agents.
KR960704536A (ko) 안트라사이클리논 유도체 및 유전분증에서의 이의 용도(Anthracyclinone derivatives and their use in amyloidosis)
TW427975B (en) Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
RU94019411A (ru) Эфиры хинук лидина, промежуточные соединения для их синтеза, фармацевтическая композиция и способ лечения
GB2063874A (en) Triazole derivatives processes for the preparation thereof and pharmaceutical compositions containing them
FI102679B1 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten sertindoli-prodrugjohdannaisten valmistamiseksi
EP0712398A1 (en) BENZOPYRANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR9307091A (pt) Acido benzenoalcanóicos para doenças cardiovasculares
CA2384018A1 (en) Muscarinic antagonists
YU9199A (en) Naphtyl compounds, intermediates, compositions, and metods for use
NO933241L (no) Aminosyrer nyttige ved terapi av osteoartikulaere paavirkninger
NO944577L (no) Hemming av effekten av amyloidogene proteiner
AU703163B2 (en) Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions
AU7130496A (en) Disubstituted piperidine derivatives
HUP0100407A2 (hu) Eljárás kinolin-karbamoil- és kinolin-tiokarbamoil-származékok előállítására és az eljárás intermedierjei
SE8401064L (sv) Nya isoxazoler och forfarande for framstellning derav
ES8504699A1 (es) Procedimiento para la obtencion de nuevos acidos aceticos heterociclicos